Follicular Thyroid Cancer - Pipeline Review, H2 2014, New Report Launched
Follicular Thyroid Cancer Pipeline Review, H2 2014 report provides comprehensive information on the therapeutic development for Follicular Thyroid Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Follicular Thyroid Cancer and special features on late-stage and discontinued projects.
View full press release